Background Egg allergy is a leading cause of food allergy in young infants; however, little is known about early allergen-specific T-cell responses which predate the presentation of egg allergy, and if these are altered by early egg exposure. Objective To investigate the early T-cell responses to multiple egg proteins in relation to patterns of egg exposure and subsequent IgE-mediated egg allergy. Methods Egg-specific T-cell cytokine responses (IL-5, IL-13, IL-10, IFNc and TNFa) to ovomucoid (OM), ovalbumin (OVA), conalbumin (CON) and lysozyme (LYS) were measured in infants with eczema at 4 months of age (n = 40), before randomization to receive 'early egg' or a placebo as part of a randomized controlled trial (Australian New Zealand Clinical Trials Registry number 12609000415202) and at 12 months of age (n = 58), when IgE-mediated egg allergy was assessed by skin prick test and food challenge. Results In 4-month-old infants, who had not directly ingested egg, those who subsequently developed egg allergy already had significantly higher Th2 cytokine responses to multiple egg allergens, particularly elevated IL-13 responses to OVA (P = 0.004), OM (P = 0.012) and LYS (P = 0.003) and elevated IL-5 to the same antigens (P = 0.031, 0.04 and 0.003, respectively). IL-13 responses (to OVA and LYS) and IL-5 responses (to LYS) at 4 months significantly predicted egg allergy at 12 months. All responses significantly declined with age in the egg-allergic infants, and this did not appear to be modified by 'early' introduction of egg. Conclusions & Clinical Relevance Elevated egg-specific Th2 cytokine responses were established prior to egg ingestion at 4 months and were not significantly altered by introduction of egg. Th2 responses at 4 months of age predicted egg allergy at 12 months, suggesting that this could be used as a biomarker to select infants for early prevention and management strategies.
Introduction
Hen's egg is one of the most common food allergens to induce T helper 2 (Th2) allergic immune responses in young infants [1] [2] [3] . IgE-mediated allergic reactions can occur early in infancy [4] , often on first ingestion of egg in solid foods [4] [5] [6] . Our previous study indicated that as many as one-third of infants with eczema may have evidence of sensitization and IgE-mediated symptoms on ingestion of egg at 4 months of age [4] . This suggests much earlier dysregulation of allergen-specific T-cell responses and that these may be established and consolidated even before 4 months of age in some children, particularly children with eczema. In addition to genetic predisposition, this increase risk has been attributed to increased sensitization risk through impaired cutaneous barrier function [7] . However, this is highly variable and not all infants with severe eczema develop egg or other food allergies. Given the risk of reactivity in this group, there is a recognized need to further characterize the proceeding immunological events leading to egg sensitization, as this may help define pathways to sensitization, facilitate early identification of children likely to react and direct potential strategies for preventive interventions in the future.
As an important prelude, this study investigated the egg allergen-specific T-cell responses in this high-risk group of children, with moderate-to-severe eczema, prior to their presentation with egg allergy. While most previous studies of egg-sensitized patients have focused on responses to ovalbumin (OVA) as the most abundant protein in hen's egg [8] [9] [10] , this study provided the opportunity to examine the early responses to a broader range of hen's egg proteins including ovomucoid (OM, Gal d 1), ovalbumin (OVA, Gal d 2), conalbumin (CON, Gal d 3) and lysozyme (LYS, Gal d 4), which are also capable of inducing the production of specific IgE [11] .
For the first time, we investigated how early patterns of T-cell responsiveness to this wider range of hen's egg allergens at 4 months of age predicted subsequent IgE-mediated egg allergy. In addition, we determined whether earlier introduction of egg in solid foods modified the subsequent egg-specific cytokine responses at 12 months of age.
Materials and methods

Subjects
The study population comprised a subset of infants who participated in a randomized controlled trial (RCT) investigating the effects of early, regular egg consumption on the development of IgE-mediated egg allergy (Australian New Zealand Clinical Trials Registry number 12609000415202). This study was approved by the Princess Margaret Hospital Human Research Ethics Committee (approval number 1635/EP), and written parental consent was obtained from all the participants. Full details of the RCT have been previously published [4] . Briefly, infants with moderate-to-severe eczema determined using a standardized Scoring Atopic Dermatitis (SCORAD) [12] score of ≥ 15 and no known ingestion of egg in solid foods were recruited at 4 months of age. The infants were randomized to receive either one teaspoon of pasteurized raw whole egg powder (intervention group) or rice powder (control group) daily from 4 to 8 months of age. At 8 months of age, cooked egg was introduced to both the intervention and control group infants after a medically observed introduction of hard-boiled egg. The primary outcome was IgE-mediated egg allergy at 12 months of age defined by a medically observed allergic reaction to a pasteurized raw egg challenge and a positive skin prick test to egg [4] . The subset of RCT participants included in this study was determined by availability of sufficient blood volume collected for cell culture analysis.
Blood collection and processing
Blood samples were collected at 4 months of age prior to any ingestion of the study powder and again at 12 months of age on the day of a skin prick test and egg challenge. Peripheral blood was collected by venipuncture into lithium-heparinized tubes and processed within 4 h. Heparinized whole blood was pelleted by centrifugation, and plasma was collected and stored at À80°C. Where blood volume allowed, cells were separated using density centrifugation (Lymphoprep TM , Axis-Shield, Oslo, Norway) method. Peripheral blood mononuclear cells (PBMCs) were isolated, washed using Roswell Park Memorial Institute (RPMI) media (Gibco Life Technology, Grand Island, NY, USA) and stored in RPMI (49%), heatinactivated foetal calf serum (43.5%) and dimethylsulphate (7.5%). Cells were stored in 1 mL aliquots at a concentration of no more than 15 9 10 6 cells/mL, transferred to a CoolCell â and immediately stored at À80°C for a standardized controlled rate of À1°C/ min cell freezing. Within 24 h of freezing, PBMCs were transferred to liquid nitrogen for long-term storage.
Mononuclear cell culture PBMC cell culture was conducted using the methods as per detailed previously [8, 13] . Briefly, cryopreserved mononuclear cells were thawed and transferred to RPMI culture media. Cells were counted, viability tested using try-pan blue (Gibco Life Technology, Grand Island, NY, USA) and transferred to AIM V (Gibco Life Technology) tissue culture media with 2-mercaptoethanol (ME) (Sigma-Aldrich Co, Sydney, NSW, Australia) at a concentration of 2 9 10 6 cells/mL. Hen's egg allergens: (a) ovalbumin (OVA 100 lg/mL), (b) ovomucoid (OVM 1 mg/mL), (c) conalbumin (CON 200 lg/mL) and d) lysozyme (LYS 500 lg/mL), all purchased from Sigma-Aldrich Co. These concentrations were identified as optimal for in vitro T-cell stimulation in preliminary titration experiments. As OVA is routinely used to stimulate PBMCs at a concentration of 100 lg/mL, this was used as the starting concentration for the other egg allergens. The concentration was deemed optimal when responses were consistent in known egg-allergic infants, while maintaining minimal responses in unaffected infants. A mitogen phytohaemagglutinin (PHA) was used as a positive control, to ensure that PBMCs were responding suitably to stimulation. Nonstimulated negative controls were also included for each infant. Lymphocytes were cultured for 48 h in 5% CO 2 incubators at 37°C before supernatants were collected and stored at À20°C for batch cytokine analysis. The number of stimulations varied between individuals and was determined by the number of available mononuclear cells.
Cytokine measurements -Luminex Xmap multiplex
Cytokines in once-thawed lymphocyte culture supernatants were quantified using Luminex Xmap multiplex technology (Luminex Corp, Austin, TX, USA) using an in-house method previously described [8] . Primary and secondary antibodies for cytokines IL-5, IL-10, IL-13, IFNc and TNFa were purchased from BD Biosciences (North Ryde, Australia). Standards for IL-5, IL-10 and IFNc were purchased from BD Bioscience, and IL-13 and TNFa standards were purchased from R&D Systems (Minneapolis, MN, USA). Quality controls were run on each plate. The lower detection limit of the assay was 3 pg/mL and the upper limit varied between 10 000 and 30 000 pg/mL. Samples that were below detection limit were assigned the value of the lowest detection (3 pg/mL). The cytokine levels were shown as the difference between the stimulated cells and control cells, which were not stimulated.
Clinical outcomes and allergy assessments
Throughout this study, an allergic reaction was defined as at least three concurrent noncontact urticaria persisting for at least 5 min and/or generalized skin erythema, and/or vomiting, and/or anaphylaxis within 2 h of allergen exposure [4] . All infants (including those that reacted to the study powder at 4 months of age) underwent an allergy assessment at 12 months of age, including a SCORAD assessment, skin prick testing, blood sample collection and egg challenge [4] . The presence of IgE-mediated egg allergy at 12 months of age was defined as a positive allergic reaction during a medically supervised raw egg challenge and evidence of sensitization (positive skin prick test) to egg, or medical advice not to proceed with the challenge due to a previous serious allergic reaction to egg.
Statistical analysis
Differences in means for parametric data were compared using t-tests. Nonparametric data were analysed between groups using Mann-Whitney U-tests. Chi-squared tests were used for comparisons of categorical data between groups. Where possible nonparametric data were logtransformed to achieve a normal distribution for the remaining statistics. Binary logistic regression was used to calculate the prediction of allergic outcomes. Paired t-tests were used to quantify changes over time. All statistics were performed using SPSS v20 (IBM, Chicago, USA), and figures were generated using Prism v 6 (GraphPad Software Inc., San Diego, CA, USA).
Results
Study population
This study included 68 infants from the clinical trial who had blood samples available for cytokine analysis, as illustrated in Fig. 1 . The baseline characteristics of this subset, shown in Table 1 , are representative of the total 86 participants in the RCT. Cytokine responses were measured in 40 infants at 4 months of age (n = 22 'early egg' intervention group, n = 18 'delayed egg' rice control group) and 58 infants at 12 months of age (n = 33 'early egg' intervention group, n = 25 'delayed egg' rice control group). For 30 infants (n = 15 'early egg' group, n = 15 'delayed egg' group), cytokine data were available at both time points. We compared t-cell responses in infants according to egg reactivity (at both 4 and 12 months) and according to the study intervention.
Baseline cytokine responses at 4 months of age and comparison of responses in 4-month-old egg reactors and nonreactors
Prior to the intervention, there were no differences in cytokine responses for IL-5 or IL-13 between the 'early egg' (intervention) and 'delayed egg' (control) group in response to any of the egg allergens: OVA, OM, CON or LYS at 4 months of age (Table 2 ). There were also no differences between the groups for IL-10, IFNc or TNFa responses as summarized in Table S1 available in the  online repository. A total of 15/49 (31%) infants in the 'early egg' intervention group had a confirmed allergic reaction to the pasteurized raw egg powder at study enrolment. Cytokine response data were available for five infants who reacted to the egg study powder and 17 infants who tolerated the egg powder. In those infants who reacted to the egg powder, egg-specific induced Th2 cytokines were significantly higher: IL-13 (OVA, OM and LYS) and IL-5 (OVA and CON) than infants who tolerated the egg powder (Fig. 2) . There was also a significantly higher production of IFNc to lysozyme in the egg powder reactors (P = 0.011) than in the nonreactors (data in Table S2 ). There were no other differences in IFNc, IL-10 or TNFa between infants who reacted and those who tolerated the egg powder at 4 months of age, data as summarized in Table S2 available in the online repository. PHA stimulation was used to assess viability in all samples, and the level of cytokines produced did not differ significantly between groups, with age or phenotype (results not shown).
Effect of the dietary intervention on cytokine responses at 12 months of age
Egg-specific Th2 cytokines IL-5 and IL-13 responses at 12 months of age did not differ according to the intervention groups (as shown in Table 3 ). No differences between the groups were also found for IL-10, IFNc or TNFa responses, as summarized in Table S3 available in the online repository.
Relationship between early cytokine responses (at 4 months) and subsequent IgE-mediated egg allergy at 12 months of age A total of 35 infants (n = 12 with IgE-mediated egg allergy) had cytokine responses measured at 4 months of age and egg allergy assessed at 12 months of age. Elevated IL-5 and IL-13 responses to egg allergens (OVA, OM, LYS) at 4 months of age were associated with IgE-mediated egg allergy at 12 months of age (Fig. 3 ). There were no associations between IL-10, TNFa and IFNc responses with IgE-mediated egg allergy, data not shown. In 30 infants (n = 11 with IgE-mediated egg allergy) with both 4 and 12 month cytokine data as well as clinical egg allergy status data at 12 months, IgEmediated egg allergy was predicted by 4 month of age OVA IL-13 (b = 1.1; 95% CI 1.09-8.7; P = 0.034), LYS IL-13 (b = 1.2; 95% CI 1.2-9.3; P = 0.03) and LYS IL-5 (b = 0.8; 95% CI 1.2-4.3; P = 0.014).
Changes in cytokine responses with age
In 30 infants (n = 11 with IgE-mediated egg allergy) with cytokine data available at both time points, infants with IgE-mediated egg allergy at 12 months of age showed a striking decrease in induced Th2 cytokine responses between 4 and 12 months of age (Fig. 4) . While all egg allergens followed the same pattern, IL-13 decreased significantly in response to stimulation with OM and LYS (P = 0.007 and P = 0.019 respectively) and IL-5 in response to LYS (P = 0.012). Infants who tolerated egg at 12 months of age did not show any significant decrease in IL-5 and IL-13 responses between 4 and 12 months (Fig. 4) .
Relationship between IgE-mediated egg allergy and cytokine responses at 12 months
At 12 months of age, 58 infants had T-cell responses measured (n = 25 with IgE-mediated egg allergy) and clinical egg allergy status data assessed at the same time point. At this age, only cytokine responses to LYS (IL-5 (P = 0.035), IL-13 (P = 0.034)) were significantly higher in infants with IgE-mediated egg allergy (Fig. 3 ). There were no significant differences for any other egg allergen for cytokines IL-5 and IL-13 (Fig. 3) . Again there were no differences for IL-10, IFNc or TNFa for any of the egg allergens, data as summarized in Table S4 available 
Relationship between eczema (SCORAD) assessments and cytokine responses
Eczema (SCORAD) assessments and cytokine data were available in 40 infants at 4 months and 58 infants at 12 months of age. There was no association between IL-5 and IL-13 responses to any of the egg proteins and eczema severity on the day of assessment for either time point. The data collected on topical steroid use were not sufficient to accurately assess in relation to cytokine production. 
Egg-specific IgG4 levels and cytokine responses
Egg-specific IgG4 levels were significantly higher in the infants who received the egg powder from 4 months of age [4] . However, production of cytokines, including egg-specific regulatory cytokine IL-10, was not correlated with the level of egg-specific IgG4 measured at 12 months of age.
Discussion
This is the first study to report patterns of infant PBMC responses to a comprehensive array of egg proteins in relation to patterns of egg exposure and subsequent egg allergy. We have confirmed strong early Th2 responses to multiple egg proteins (OVA, OM, CON and LYS) in a high proportion of infants with eczema by 4 months of age, prior to the introduction of egg in solid foods. Moreover, IL-5 and IL-13 responses at this age predicted the development of challenge-proven egg allergy later in infancy. These findings clearly demonstrate that immunological events leading to egg sensitization are commonly initiated prior to the introduction of egg in solid foods, particularly in this high-risk phenotype. This highlights the need to understand other potential mechanisms and routes of sensitization, during lactation or even in utero. Egg proteins are known to cross the placenta [14] and have been detected in breast milk [15] , providing potential avenues of exposure. Transcutaneous exposure also may be a particularly important route of exposure in children with moderate-to-severe eczema [7] . In addition to impaired skin barrier function, children with eczema also show evidence of increased gut mucosal permeability [16, 17] , which may provide an additional mechanism in dysregulation of mucosal responses and the development of food allergy. On the other hand, many children without eczema still develop food allergy, and it will be important to repeat these studies in egg-allergic children without eczema.
Another interesting finding in this study was that the intervention with early regular oral exposure to egg from 4 months of age was not associated with any significant effects on egg-specific IL-5, IL-10, IL-13, IFNc or TNFa cytokine responses. This could be because Th2 cytokine production was already well established in many infants by 4 months of age prior to the intervention. It is also recognized that the development of oral tolerance is not necessarily associated with the reduction in allergen-specific IgE or underlying Th2 responses, as noted in studies of oral immunotherapy [18] . Other immunological parameters, such as allergenspecific IgG4, are more consistently associated with oral tolerance. Indeed, we have previously noted that this intervention was associated with significantly higher egg-specific IgG4 levels at 12 months of age compared to the 'delayed egg' control group [4] . However, while this suggests that the early, regular introduction of egg did influence underlying tolerance-associated cellular mechanisms, we did not see any continuous effects on the production of cytokines such as IL-10 and IFNc, which have been associated with tolerance in other studies [19] . While egg-allergic infants did produce significantly higher levels of IFNc in response to lysozyme at 4 months of age, this was a stand-alone result in only five infants, and it is therefore not possible to draw any conclusions about early egg-specific regulatory responses. It is possible that the intervention induced changes in regulatory T-cell function, but for logistic reasons and small sample volumes, it was not possible to examine this. The dynamics of the T-cell responses were also of significant interest in this population. It is notable that both IL-5 and IL-13 Th2 responses were more pronounced at 4 months and waned with age, even in children who had IgE-mediated reactions at 12 months of age on challenge. By 12 months, only LYS IL-5 and IL-13 remained significantly elevated in egg-allergic children. In particular, IL-13 responses to other egg allergens (OVA, OM and CON) were comparable to the nonallergic children, despite continued clinical reactivity. Although LYS makes up a small percentage of total egg protein (3.5%) [20] , up to 35% of egg-allergic patients have been shown to produce LYS-specific IgE [21] . Thus, LYS seems to be inducing more sustained egg-specific inflammatory responses, with higher and more persistent production of IL-5 and IL-13 than the other egg proteins.
In conclusion, we have demonstrated that four egg proteins (OVA, OM, CON and LYS) are capable of inducing Th2 cytokine responses associated with the presence of IgE-mediated egg allergy. In addition, we have shown that these egg-induced immune responses at 4 months of age predicted egg allergy outcomes at 12 months of age. These results suggest that early eggspecific T-cell responses may have a long-lasting effect in egg allergy development pathways. With egg allergy now one of the most common food allergies affecting children in early childhood [3] , this study is demonstrating a need for further investigation of the influence of egg protein exposures in early life, prior to the introduction of solid foods, on the development of eggspecific Th2 cytokine responses.
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